|
CH630257A5
(en)
*
|
1975-03-17 |
1982-06-15 |
Hoffmann La Roche |
Sustained release formulation
|
|
US4140755A
(en)
*
|
1976-02-13 |
1979-02-20 |
Hoffmann-La Roche Inc. |
Sustained release tablet formulations
|
|
US4167558A
(en)
*
|
1976-02-13 |
1979-09-11 |
Hoffmann-La Roche Inc. |
Novel sustained release tablet formulations
|
|
US4207890A
(en)
*
|
1977-01-04 |
1980-06-17 |
Mcneilab, Inc. |
Drug-dispensing device and method
|
|
JPS6024767B2
(ja)
*
|
1979-08-24 |
1985-06-14 |
塩野義製薬株式会社 |
腸溶性硬カプセル剤
|
|
DE3278491D1
(en)
*
|
1981-07-15 |
1988-06-23 |
Key Pharma |
Sustained release theophyline
|
|
US4451260A
(en)
*
|
1982-03-26 |
1984-05-29 |
Minnesota Mining And Manufacturing Company |
Sustained release oral medicinal delivery device
|
|
JPS5953410A
(ja)
*
|
1982-09-20 |
1984-03-28 |
Fujisawa Pharmaceut Co Ltd |
新型ソフトカプセル剤
|
|
JPS59193831A
(ja)
*
|
1983-04-18 |
1984-11-02 |
Sankyo Co Ltd |
腸溶性製剤の製造法
|
|
US4505890A
(en)
*
|
1983-06-30 |
1985-03-19 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation and method
|
|
SE457505B
(sv)
*
|
1984-01-10 |
1989-01-09 |
Lejus Medical Ab |
Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
|
|
DK62184D0
(da)
*
|
1984-02-10 |
1984-02-10 |
Benzon As Alfred |
Diffusionsovertrukket polydepotpraeparat
|
|
US4610870A
(en)
*
|
1984-10-05 |
1986-09-09 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
JPS61107782U
(enExample)
*
|
1984-12-19 |
1986-07-08 |
|
|
|
US4735804A
(en)
*
|
1985-05-10 |
1988-04-05 |
Merck & Co., Inc. |
Drug delivery device which can be retained in the stomach for a controlled period of time
|
|
US4767627A
(en)
*
|
1985-05-29 |
1988-08-30 |
Merck & Co., Inc. |
Drug delivery device which can be retained in the stomach for a controlled period of time
|
|
US4758436A
(en)
*
|
1985-05-29 |
1988-07-19 |
Merck & Co., Inc. |
Drug delivery device which can be retained in the stomach for a controlled period of time
|
|
US4666705A
(en)
*
|
1985-06-03 |
1987-05-19 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
US4756911A
(en)
*
|
1986-04-16 |
1988-07-12 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
US4814178A
(en)
*
|
1987-07-01 |
1989-03-21 |
Sanford Bolton |
Floating sustained release therapeutic compositions
|
|
DE3803482A1
(de)
*
|
1988-02-05 |
1989-08-17 |
Lohmann Therapie Syst Lts |
Schwimmfaehiges orales therapeutisches system
|
|
JPH082781B2
(ja)
*
|
1988-10-18 |
1996-01-17 |
嘉明 川島 |
中空顆粒状医薬及びその製法
|
|
JPH05507717A
(ja)
*
|
1990-06-25 |
1993-11-04 |
ザ・デュポン・メルク・ファーマシュウティカル・カンパニー |
軟ゼラチンカプセル剤中で使用するための高められた溶解特性を有するアマンタジン塩酸塩懸濁液
|
|
US5232704A
(en)
*
|
1990-12-19 |
1993-08-03 |
G. D. Searle & Co. |
Sustained release, bilayer buoyant dosage form
|
|
US5198229A
(en)
*
|
1991-06-05 |
1993-03-30 |
Alza Corporation |
Self-retaining gastrointestinal delivery device
|
|
US5314696A
(en)
*
|
1991-06-27 |
1994-05-24 |
Paulos Manley A |
Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
|
|
DE4406424A1
(de)
*
|
1994-02-28 |
1995-08-31 |
Bayer Ag |
Expandierbare Arzneiformen
|
|
JP2671257B2
(ja)
*
|
1995-07-13 |
1997-10-29 |
エーザイ株式会社 |
溶解遅延性ゼラチン製剤組成物
|
|
SE9702533D0
(sv)
|
1997-07-01 |
1997-07-01 |
Astra Ab |
New oral formulation
|
|
IN186245B
(enExample)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
|
KR100620935B1
(ko)
|
1998-03-19 |
2006-09-13 |
브리스톨-마이어스스퀴브컴파니 |
용해도가 높은 약물에 대한 2상 서방성 전달 시스템과 방법
|
|
EP1245227A1
(en)
*
|
2001-03-31 |
2002-10-02 |
Jagotec Ag |
A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
|
|
US20030203027A1
(en)
*
|
2002-04-26 |
2003-10-30 |
Ethicon, Inc. |
Coating technique for deposition of drug substance on a substrate
|
|
US20040086566A1
(en)
*
|
2002-11-04 |
2004-05-06 |
Alpharma, Inc. |
Waxy matrix dosage forms
|
|
US7485322B2
(en)
*
|
2002-12-24 |
2009-02-03 |
Lek Pharmaceuticals D.D. |
Modified release pharmaceutical composition
|
|
DE602004016963D1
(en)
*
|
2003-02-21 |
2008-11-20 |
Lek Pharmaceuticals |
Therapeutisches system mit amoxicillin und clavulansäure
|
|
JP2007510654A
(ja)
*
|
2003-11-04 |
2007-04-26 |
スパーナス ファーマシューティカルズ インコーポレイテッド |
分極した酸素原子を有するポリマーを含むマトリクスからの正に荷電した薬理学的活性分子の徐放
|
|
CN101511346B
(zh)
*
|
2006-09-04 |
2012-07-04 |
万能药生物有限公司 |
可编制的漂浮递送技术
|
|
WO2010020098A1
(zh)
*
|
2008-08-18 |
2010-02-25 |
北京天衡药物研究院 |
胃滞留药物释出系统及其制备方法和用途
|
|
WO2009087665A2
(en)
*
|
2007-12-11 |
2009-07-16 |
Vishwanath Sudhir Nande |
Novel gastroretentive drug delivery system
|
|
GB2460915B
(en)
*
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
|
|
FR2945945B1
(fr)
*
|
2009-05-29 |
2011-07-29 |
Flamel Tech Sa |
Procede de preparation de particules creuses et leurs applications
|
|
FR2945947B1
(fr)
|
2009-05-29 |
2011-07-29 |
Flamel Tech Sa |
Compositions pharmaceutiques flottantes a liberation controlee
|
|
CA2767143A1
(en)
*
|
2009-07-06 |
2011-01-13 |
Kyorin Pharmaceutical Co., Ltd. |
Tablet having hollow structure
|
|
ES2651743T3
(es)
*
|
2010-07-05 |
2018-01-29 |
Jagotec Ag |
Forma farmacéutica
|
|
BR112014000773A8
(pt)
*
|
2011-07-14 |
2017-10-03 |
Apet Holding B V |
Composições de nicotinamida e uso terapêutico das mesmas
|
|
WO2013054285A1
(en)
|
2011-10-11 |
2013-04-18 |
Ranbaxy Laboratories Limited |
A gastroretentive dosage system and process of preparation thereof
|
|
CA2879282C
(en)
*
|
2012-07-16 |
2022-05-03 |
Hendrik Jan Cornelis Meijerink |
Gastro-retentive drug delivery system
|
|
HUE025008T2
(en)
|
2012-10-12 |
2016-04-28 |
Omya Int Ag |
Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate
|
|
CN106714893B
(zh)
|
2014-06-11 |
2021-01-01 |
麻省理工学院 |
自组装的驻留装置及相关方法
|
|
US20170266112A1
(en)
|
2014-06-11 |
2017-09-21 |
Massachusetts Institute Of Technology |
Residence structures and related methods
|
|
EP3034070A1
(en)
|
2014-12-18 |
2016-06-22 |
Omya International AG |
Method for the production of a pharmaceutical delivery system
|
|
CN104706613B
(zh)
*
|
2015-03-20 |
2018-01-16 |
华侨大学 |
一种胃漂浮空心缓释片的制备方法
|
|
EP3069713A1
(en)
|
2015-03-20 |
2016-09-21 |
Omya International AG |
Dispersible dosage form
|
|
CN107592803B
(zh)
|
2015-05-01 |
2021-01-22 |
麻省理工学院 |
可触发形状记忆感应装置
|
|
HK1258050A1
(zh)
|
2015-10-23 |
2019-11-01 |
Lyndra Therapeutics, Inc. |
用於治疗剂缓释的胃驻留系统及其使用方法
|
|
WO2017100367A1
(en)
|
2015-12-08 |
2017-06-15 |
Lyndra, Inc. |
Geometric configurations for gastric residence systems
|
|
CA3018011A1
(en)
*
|
2016-03-18 |
2017-09-21 |
Grunenthal Gmbh |
Floating pharmaceutical dosage form
|
|
AU2017268840B2
(en)
|
2016-05-27 |
2022-02-10 |
Lyndra Therapeutics, Inc. |
Materials architecture for gastric residence systems
|
|
EP3269361A1
(en)
|
2016-07-14 |
2018-01-17 |
Omya International AG |
Dosage form
|
|
WO2018064630A1
(en)
|
2016-09-30 |
2018-04-05 |
Lyndra, Inc. |
Gastric residence systems for sustained delivery of adamantane-class drugs
|
|
CA3066658A1
(en)
|
2017-06-09 |
2018-12-13 |
Lyndra, Inc. |
Gastric residence systems with release rate-modulating films
|
|
WO2021176361A1
(en)
*
|
2020-03-02 |
2021-09-10 |
Craft Health Pte Ltd |
Method of manufacturing oral dosage forms for extended drug release
|
|
ES2955784T3
(es)
*
|
2020-10-14 |
2023-12-07 |
Hannes Bichsel |
Granos biogranulados espumados
|
|
WO2023166225A1
(en)
*
|
2022-03-04 |
2023-09-07 |
APET Holding B.V. |
Digestive enzyme formulations
|